Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-10-13
1999-09-28
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514649, 514651, 514811, A61K 31415, A61K 31135
Patent
active
059589620
ABSTRACT:
The invention relates to a method of treating alcoholism and alcohol dependence in a mammal comprising administering to the mammal a therapeutically effective amount of a synergistic combination of: (i) at least one opioid antagonist, and (ii) at least one selective serotonin reuptake inhibitor. The invention also relates to compositions and kits containing the same.
REFERENCES:
patent: 4777173 (1988-10-01), Shrotryia
patent: 5366990 (1994-11-01), Reid
Ferrero, et al., Medicine & Hygiene, Acquisitions Therapeutiques 1993 (II) 52: 93-6.
Benjamin and Buot-Smith, J. Am. Acad. Child Adolesc. Psychiatry, Naltrexone and Fluoxetine in Prader-Willi Syndrome 32:4, Jul. 1993.
Bohn, The Psychiatric Clinics of North America, Alcoholism 16:4, 1993.
J. R. Volpicelli et al., Arch. Gen. Psychiatry, 1992 49:876.
S. S. O'Malley et al., Arch. Gen Psychiatry, 1992, 49:881.
D. R. Brown & S. G. Holtzman, Pharmacol. Biochem. Behav., 1979, 11:567.
L. D. Reid & G. A. Hunter, Alcohol, 1984, 1:33.
C. L. Hubbell et al., Alcohol, 1986, 3:39.
R. D. Myers et al., Alcohol, 1986, 3:383.
C. L. Hubbell et al., Alcohol, 1991, 8:355.
D. V. Gauvin et al., Alcohol, 1993 10:37.
C. A. Narango et al., Clin. Pharm. Ther., 1984 35:374.
C. A. Narango et al., Clin. Pharm. Ther., 1987 41:266.
C. A. Narango et al., J. Clin. Psychiatry., 1986, 47:16.
Criares Theodore J.
DuPont Pharmaceuticals Company
Kondrad Karen H.
LandOfFree
Combination of an opioid antagonist and a selective serotonin re does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of an opioid antagonist and a selective serotonin re, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of an opioid antagonist and a selective serotonin re will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703845